Clinical trials
NAFLD (Nonalcoholic Fatty Liver Disease) clinical trials
Below are recruiting nafld (nonalcoholic fatty liver disease) clinical trials, each written for real people, not researchers. We’re tracking 30 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07662356Recruiting
NAFLD study in Chinese patients having obesity surgery
This study follows Chinese patients who are having obesity surgery to understand how nonalcoholic fatty liver disease (NAFLD) changes over time and to find markers that might predict its course. It could help doctors better treat liver problems in people with obesity.
Hong Kong, New TerritoriesAges 18 years+ - NCT07564947Enrolling by invitation
Reishi Mushroom for Fatty Liver Disease
This study tests whether Ganoderma lucidum (reishi mushroom) can improve liver health and reduce inflammation in people with fatty liver disease. Researchers will measure how it affects your liver function and antioxidant levels.
Peshawar, Khyber PakhtunkhwaAges 35–49 - NCT07493967Enrolling by invitation
Stomach balloon for fatty liver disease study
This study looks at how a stomach balloon affects symptoms and quality of life in people with obesity and fatty liver disease. It will track your health over time to see if the balloon helps.
Dallas, TexasAges 18 years+ - NCT03190538Recruiting
Study of fatty liver inflammation in Chinese children
This trial looks at nonalcoholic steatohepatitis (fatty liver with inflammation) in children. It is meant to test whether a new approach can help improve this liver problem without being caused by alcohol or other known liver diseases.
BeijingAges 1–18 - NCT06335771Recruiting
Study on fat metabolism in obesity and diabetes
This study looks at how fat is processed in the body for people with different health conditions, including obesity and type 2 diabetes. It aims to find new ways to improve treatment by understanding these differences.
Columbia, MissouriAges 18–70 - NCT04014413Recruiting
Fecal transplant for gut and immune-related conditions
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
Hong Kong, ShatinAges Any age
Hear when a new NAFLD (Nonalcoholic Fatty Liver Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for nafld (nonalcoholic fatty liver disease)?
- Yes. Clin2 currently lists 30 recruiting nafld (nonalcoholic fatty liver disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a nafld (nonalcoholic fatty liver disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a nafld (nonalcoholic fatty liver disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.